Drug Recalls and Withdrawals
For a full list of all current Class 1 drug recalls and withdrawals, please see below:
Alvogen announced a voluntary, consumer level recall of one lot of fentanyl transdermal system 25 mcg/h transdermal patches because there is a potential that patches could be multi-stacked, adhered one on top of the other, in a single product pouch.
For more information, please click here.
Amneal announced a voluntary, consumer level recall of three lots of sulfamethoxazole/trimethoprim tablets because the tablets may exhibit black spots on the tablet surface due to microbial contamination. For more information, please click here.
07/09/2024
Endo announced a consumer level recall of one lot of clonazepam orally disintegrating 0.25 mg tablets because they may have been packaged in a carton labelled as 0.125 mg. For more information, please click here.
06/25/2024
Glenmark announced a consumer level recall of 114 lots of potassium chloride extended-release capsules because they may not dissolve correctly which may lead to hyperkalemia. On 08/09/2024, WHA was notified by OptumRx that the recall classification type had been updated to class 1. For more information, please click here.